Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (Q37219981)
scientific article published on 25 January 2004
Language:
(P31) (Q13442814)
(P50) (Q7286601)
(Q88652265)
(Q114292133)
(Q96071178)
(Q125211340)
(P304) 145-147
(P407) (Q1860)
(P433) 2
(P478) 10
(P577) Sunday, January 25, 2004
(P921) (Q413299)
(Q79460)
(P1433) (Q1633234)
(P1476) "Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer" (language: en)
(P2093) Christopher G Willett
Yves Boucher
Dan G Duda
Ricky T Tong
Daniel C Chung
Dushyant V Sahani
Sanjeeva P Kalva
Sergey V Kozin
Mari Mino
Kenneth S Cohen
Alan C Hartford
Alan J Fischman
Jeffrey W Clark
David P Ryan
Andrew X Zhu
Helen X Chen
Paul C Shellito
Gregory Y Lauwers
(P2860) (Q36509678)
(Q33187344)
(Q29614540)
(Q27860704)
(Q34988256)
(Q34157098)
(Q34152769)
(Q34354300)
(Q27861015)
(Q37051843)
(Q41140320)
(Q44474956)
(Q54033425)
(Q73919503)
(Q73963380)
other details
description scientific article published on 25 January 2004

External Links